J. E. Davis
CEO and President, Director at Quest Diagnostics Inc (DGX)
J. E. Davis has filed 24 insider reports with the SEC since February 2021, as CEO and President and director at Quest Diagnostics Inc (DGX). In the last 12 months J. E. Davis sold $17.1M of stock on the open market. In the latest filing, on September 3, 2026, J. E. Davis sold 10,000 shares of Quest Diagnostics Inc (DGX) for $2.43M at an average of $242.72.
- Filings
- 24
- Companies
- 1
- Bought on market
- None
- Sold on market
- $23.7M
Companies where J. E. Davis is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| CEO and President, Director | 122,423 | $23.7M | $259.69 | Sep 3, 2026 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Sep 1, 2026-$2.43MDGXCEO and President Davis J. E. sold $2,427,200 worth of shares (10,000 units at $242.72) as part of a pre-agreed trading plan, decreasing direct ownership by 8% to 122,423 unitsForm 4Open-market sale10b5-1 plan
- Jun 1, 2026-$1.94MDGXCEO and President Davis J. E. sold $1,941,400 worth of shares (10,000 units at $194.14) as part of a pre-agreed trading plan, decreasing direct ownership by 7% to 132,423 unitsForm 4Open-market sale10b5-1 plan
- Mar 4, 2026DGXCEO and President Davis J. E. was granted 51,652 shares and covered exercise/tax liability with 26,414 shares, increasing direct ownership by 22% to 142,423 unitsForm 4Grant or awardShares withheld for taxes or exercise price
- Mar 2, 2026-$2.13MDGXCEO and President Davis J. E. covered exercise/tax liability with 2,968 shares and sold $2,125,200 worth of shares (10,000 units at $212.52), decreasing direct ownership by 10% to 117,185 unitsForm 4Shares withheld for taxes or exercise priceOpen-market sale10b5-1 plan
- Mar 2, 2026~$2.13MDGXJ. E. Davis plans to sell 10,000 shares (~$2.13M)Form 144Planned sale10b5-1 plan
- Feb 18, 2026DGXCEO and President Davis J. E. was granted 15,857 shares and covered exercise/tax liability with 6,184 shares, increasing direct ownership by 8% to 130,153 unitsForm 4Grant or awardShares withheld for taxes or exercise price
- Nov 25, 2025-$10.6MDGXCEO and President Davis J. E. exercised 55,093 shares at a strike of $95.80 and sold $10,589,760 worth of shares (55,093 units at $192.22)Form 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Nov 5, 2025DGXCEO and President Davis J. E. covered exercise/tax liability with 7,143 shares, decreasing direct ownership by 6% to 120,480 unitsForm 4Shares withheld for taxes or exercise price
- Apr 2, 2025-$6.6MDGXCEO and President Davis J. E. sold $6,602,074 worth of shares (39,191 units at $168.46), decreasing direct ownership by 23% to 127,623 unitsForm 4Open-market sale10b5-1 plan
- Mar 4, 2025DGXCEO and President Davis J. E. covered exercise/tax liability with 33,318 shares and was granted 61,917 shares, increasing direct ownership by 21% to 166,814 unitsForm 4Grant or awardShares withheld for taxes or exercise price
- Feb 26, 2025DGXCEO and President Davis J. E. covered exercise/tax liability with 2,966 shares, decreasing direct ownership by 2% to 138,215 unitsForm 4Shares withheld for taxes or exercise price
- Feb 19, 2025DGXCEO and President Davis J. E. covered exercise/tax liability with 2,936 shares, decreasing direct ownership by 2% to 141,181 unitsForm 4Shares withheld for taxes or exercise price
- Feb 12, 2025DGXCEO and President Davis J. E. was granted 18,149 shares, increasing direct ownership by 14% to 144,117 unitsForm 4Grant or award
- Feb 28, 2024DGXDavis J. E. covered exercise/tax liability with 5,020 shares, decreasing direct ownership by 4% to 125,968 unitsForm 4Shares withheld for taxes or exercise price
- Feb 23, 2024DGXDavis J. E. was granted 13,390 shares and covered exercise/tax liability with 6,525 shares, increasing direct ownership by 6% to 130,988 unitsForm 4Grant or awardShares withheld for taxes or exercise price
- Feb 21, 2024DGXDavis J. E. covered exercise/tax liability with 762 shares, decreasing direct ownership by 0.61% to 124,123 unitsForm 4Shares withheld for taxes or exercise price
- Feb 14, 2024DGXDavis J. E. was granted 22,251 shares, increasing direct ownership by 22% to 124,885 unitsForm 4Grant or award
- Mar 6, 2023DGXSEC Form 4: Davis J. E. was granted 15,204 shares and covered exercise/tax liability with 8,036 shares, increasing direct ownership by 8% to 102,634 units to satisfy tax liabilityForm 4Grant or awardShares withheld for taxes or exercise price
- Nov 1, 2022DGXSEC Form 4: Davis J. E. was granted 13,980 shares, increasing direct ownership by 21% to 80,788 unitsForm 4Grant or award
- Mar 7, 2022DGXSEC Form 4: Davis J. E. was granted 19,856 shares and covered exercise/tax liability with 10,330 shares, increasing direct ownership by 17% to 66,808 units (for withholding tax)Form 4Grant or awardShares withheld for taxes or exercise price
- Feb 24, 2022DGXSEC Form 4: Davis J. E. was granted 9,787 shares, increasing direct ownership by 21% to 57,282 unitsForm 4Grant or award
- Mar 9, 2021DGXSEC Form 4: E. J. Davis was granted 16,570 units of Common Stock and disposed of $961,910 worth of Common Stock (8,334 units at $115.42), increasing direct ownership by 20% to 49,931 unitsForm 4Grant or awardShares withheld for taxes or exercise price
- Feb 24, 2021DGXSEC Form 4: E. J. Davis disposed of $249,117 worth of Common Stock (2,056 units at $121.17), decreasing ownership by 5% to 41,695 unitsForm 4Shares withheld for taxes or exercise price
- Feb 17, 2021DGXSEC Form 4: E. J. Davis was granted 5,665 units of Common Stock, increasing ownership by 15% to 43,751 unitsForm 4Grant or award
Compare J. E. Davis with
- J. E. Davis vs Michael J Deppe1 shared
- J. E. Davis vs Patrick Plewman1 shared
- J. E. Davis vs Subu Ramachandran1 shared
- J. E. Davis vs Catherine T. Doherty1 shared
- J. E. Davis vs Mark E Delaney1 shared
- J. E. Davis vs Timothy C Wentworth1 shared
Other insiders at the same companies
- Michael J DeppeDGX
- Patrick PlewmanDGX
- Subu RamachandranDGX
- Catherine T. DohertyDGX
- Mark E DelaneyDGX
- Timothy C WentworthDGX
- Michael E PrevoznikDGX
- Karthik KuppusamyDGX
- Robert B CarterDGX
- Vicky B GreggDGX
- Timothy L MainDGX
- Sam SamadDGX
- Wright Lassiter IIIDGX
- Luis DiazDGX
- Tracey DoiDGX
- Timothy M RingDGX
Questions about J. E. Davis
- What is J. E. Davis's role at Quest Diagnostics Inc?
- J. E. Davis reports to the SEC as CEO and President and director at Quest Diagnostics Inc (DGX), according to the latest filing on September 3, 2026.
- How many shares does J. E. Davis own?
- After the latest filing that states it, J. E. Davis directly owned 122,423 shares of Quest Diagnostics Inc (DGX). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has J. E. Davis bought or sold stock recently?
- The most recent open-market sale was on September 1, 2026: sold 10,000 shares of Quest Diagnostics Inc (DGX) for $2.43M at an average of $242.72.
- How do I get alerts when J. E. Davis files?
- Follow J. E. Davis on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. J. E. Davis filed 1 time in the last 90 days.
From SEC Forms 3, 4, 5 and 144 filed by J. E. Davis (SEC CIK 0001599837). Totals count each trade once, skipping amendments whose original is on file, from Feb 20, 2021 on. View on SEC EDGAR